EDWARDS LIFESCIENCES CORP
NYSE: EW (Edwards Lifesciences Corporatio)
Kemas kini terakhir: 7 jam lalu90.78
-0.09 (-0.10%)
| Penutupan Terdahulu | 90.87 |
| Jumlah Dagangan | 2,778,056 |
| Harga / Pendapatan (P/E Ke hadapan) | 30.30 |
| Harga / Jualan (P/S) | 8.11 |
| Harga / Buku (P/B) | 4.93 |
| Julat 52 Minggu |
| Margin Keuntungan | 75.71% |
| Margin Operasi (TTM) | 29.01% |
| EPS Cair (TTM) | 2.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 6.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 1.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.86% |
| Nisbah Semasa (MRQ) | 4.45 |
| Aliran Tunai Operasi (OCF TTM) | 876.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.45 B |
| Pulangan Atas Aset (ROA TTM) | 8.42% |
| Pulangan Atas Ekuiti (ROE TTM) | 16.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Edwards Lifesciences Corporatio | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 2.5 |
| Purata | -0.88 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.91% |
| % Dimiliki oleh Institusi | 89.29% |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |